What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?

Journal article

Peer reviewed

Ernest S. Han and Bradley J. Monk

Gynecologic oncology, Vol.105(1), pp.3-6

04/01/2007

PMID: 17383545

Abstract

Life Sciences & Biomedicine

Obstetrics & Gynecology

Oncology

Science & Technology

6 Record Views

Title: What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
Creators: Ernest S. Han
Bradley J. Monk
Publication Details: Gynecologic oncology, Vol.105(1), pp.3-6
Publisher: Elsevier
Number of pages: 4
Identifiers: 991005969068602656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article